简体中文

Who We Are

BeyondSpring is a Global, Clinical-Stage
Bio-pharmaceutical Company

Developing Innovative Immuno-Oncology Cancer Therapies with a Robust Pipeline from Internal Development and from Collaboration with University of Washington in De Novo Drug Discovery Using a Ubiquitination Platform.

Detail



Development

Pipeline

We have a robust drug development pipeline at various clinical and pre-clinical stages.

Read More
News
More >
Media
More >

© 2020 BeyondSpring Inc. All rights reserved.